A new study led by Dr. Yahaira de Tamayo-Ordóñez and Dr. Ninfa Rosas-García from Instituto Politécnico Nacional, uncovers how certain RNA components in the SARS-CoV-2 virus change over time, helping the virus to survive, spread, and mutate. This research, published in Current Issues in Molecular Biology, used advanced computer models to explore specific RNA structures, such as loops and knots, which are crucial to the virus’s ability to reproduce.
Dr. Yahaira de Tamayo-Ordóñez and Dr. Ninfa Rosas-García found that these RNA elements, known as “cis elements,” play a vital role in controlling how the virus operates, including its ability to copy itself and produce proteins. By examining these elements in different variants of the virus, they discovered that these structures are flexible and adaptable, allowing the virus to change in ways that help it evade the immune system. As Dr. Tamayo-Ordóñez explained, “The flexibility of these RNA structures helps the virus adapt and survive, which is why understanding them can provide valuable insights for developing treatments.”
Cis elements are found in important sections of the virus’s genome and are responsible for many critical processes. The researchers focused on these structures in various regions of the SARS-CoV-2 genome and found that they play a central role in the virus’s ability to evolve. Dr. Rosas-García added, “These RNA structures are not only conserved but also able to adjust their sequence, which allows the virus to continue adapting and remain a serious threat.”
Another focus of the study was on a specific RNA structure called s2m, located in a region of the virus’s genome that influences how the virus interacts with its host. This structure has evolved along with the virus, helping it avoid detection by the immune system. Variants like Omicron and Eris showed changes in the s2m structure, suggesting that these alterations may have contributed to their rapid spread and ability to evade immunity. The adaptability of this structure is an important area for future research, as targeting it could be a potential strategy for developing treatments that stop the virus in its tracks.
To better understand how these RNA structures change, the team used computer programs to predict their shapes. They found that the stability of these structures, which are essential for the virus to function properly, varied among different virus variants. These slight changes may impact how easily the virus can replicate and spread. As Dr. Rosas-García noted, “Even small differences in these structures can lead to significant changes in how the virus behaves, potentially explaining why some variants are more infectious than others.”
The study’s results highlight the importance of these evolving RNA structures in understanding the virus’s behavior. Dr. Tamayo-Ordóñez pointed out that targeting these structures could offer new ways to fight the virus, saying, “By focusing on these key elements, particularly structures like the pseudoknot and s2m, we may be able to develop therapies that block the virus’s ability to reproduce and spread.”
This research opens up new possibilities for treating COVID-19 and provides critical information about how the virus adapts. With these insights, scientists can work towards developing more effective treatments that can keep up with the virus’s rapid evolution.
Journal Reference
Tamayo-Ordóñez, Y. d. J., Rosas-García, N. M., et al. “Genomic Evolution Strategy in SARS-CoV-2 Lineage B: Coevolution of Cis Elements.” Curr. Issues Mol. Biol., 2024, 46, 5744–5776. DOI: https://doi.org/10.3390/cimb46060344
About the Authors
Dr. Yahaira de Jesús Tamayo Ordóñez is a leading researcher in the field of biotechnology, with a solid academic background and a career that ranges from cutting-edge research to the creation of innovative solutions for health, sustainability and environmental problems. With two postdoctoral stays at the Autonomous University of Coahuila and the Center for Genomic Biotechnology of the National Polytechnic Institute, she has consolidated her experience in Microevolution and Biomedical Biotechnology, areas in which she addresses Mexico’s challenges through a collaborative and interdisciplinary approach. Her membership in the National System of Researchers (SNI), the National Society of Biotechnology and Engineering (SONABIIN) and her co-founding of the microenterprise Innovación Biotecnología TO (INBIOTO) demonstrate her commitment to both academic research and technology transfer and applied innovation. Since October 2022, Dr. Tamayo has been involved in a comprehensive project studying the evolution of the SARS-CoV-2 coronavirus, searching for possible drugs to counteract its effects. This work is crucial for the development of advanced approaches for the detection and accessible diagnosis of new variants, a vital aspect for anticipating and mitigating the impact of future pandemics.
Dr. Ninfa M. Rosas-García heads the Environmental Biotechnology Laboratory at the CBG-IPN in Reynosa, Tamp., Mexico. She holds a PhD in Biotechnology Sciences from UANL. Her research focuses on the biological control of insect pests and studying microorganisms with degrading capacities for xenobiotic products. From 2010 to 2014, she served as Director of the CBG and later did a sabbatical year at the AgriLife Research Center at Texas A&M University for the improvement and resistance to pests of Mexican lime. Dr. Rosas has served as technical manager of various research projects with internal and external funding and has also directed various undergraduate, master’s, and doctoral theses. She has published 69 research articles in indexed journals and several book chapters and served as editor of an international book. Dr. Rosas has collaborations abroad, mainly in the United States and India. Currently, Dr. Rosas continues working on the biological control of insect pests that attack crops of economic importance for the country and is also focused on the study and production of secondary metabolites produced by fungi and bacteria to determine their entomopathogenic, biodegrading and antimicrobial capacities for the development of products that impact the benefit of agriculture and the environment.
